Company Filing History:
Years Active: 2021-2024
Title: The Innovations of Mikhail Samsonov: Pioneering Therapeutic Solutions
Introduction
Mikhail Samsonov, an accomplished inventor based in Moscow, Russia, has made significant strides in the field of therapeutic compositions. With two patents under his name, his work focuses on innovative solutions that address the modulation of human IL-1β activity, offering new possibilities for disease treatment and prevention.
Latest Patents
Mikhail's latest patents revolve around the development of IL1-R1 derived inhibitors of IL-1β. These therapeutic compositions are designed to treat or prevent diseases associated with the modulation of human IL-1β activity. The inventions highlight the engineering of a heterodimeric protein assembly capable of binding to human IL-1β and attenuating its functions. Each component of the assembly consists of extracellular portions of the human IL1-R1 and human IL-1RAcP, or their functional fragments. These portions are fused to distinct mutants of the Fc portion of human Ig Gamma-1. The engineering approach favors the formation of heteromeric dimers over homomeric assemblies, enhancing the effectiveness of the therapeutic solutions for both humans and animals.
Career Highlights
During his career, Mikhail Samsonov has consistently focused on biopharmaceutical innovations, particularly in the realm of immunology and therapeutic proteins. His expertise has contributed to important advancements in understanding and leveraging biological functions for therapeutic applications.
Collaborations
Mikhail works alongside notable colleagues such as Alexey Repik and Vasily Ignatiev, collaborating on projects that enhance the development and application of their innovative therapeutic compositions. This teamwork fosters a creative environment that promotes the exchange of ideas and accelerates the pace of research and development in their field.
Conclusion
Mikhail Samsonov exemplifies the spirit of innovation in the biopharmaceutical arena. His contributions not only hold the potential for significant advancements in treatment modalities but also reflect the collaborative efforts and dedication of inventors pushing the boundaries of science for the benefit of society.